Top Markets
#1 Siren Siren +35.00%
#2 TDCCP TDCCP +20.44%
#3 aelf aelf +17.29%
#4 DAPPOS DAPPOS +14.71%
#5 Status Status +7.72%
#6 Tutorial Tutorial +7.24%
#7 DeXe DeXe +6.91%
#8 GRVT Token GRVT Token +6.69%
#9 HOME HOME +6.45%
#10 OpenGradient OpenGradient +6.28%
Coin of the day
Siren Siren
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Uniphar plc Uniphar plc

Uniphar plc

UPR
Rang in Aktien #8235
Uniphar plc functions as a multifaceted healthcare solutions provider, serving... Uniphar plc functions as a multifaceted healthcare solutions provider, serving markets across the Republic of Ireland, the United Kingdom, and various international territories. Its operations are segmented into three primary divisions: Commercial & Clinical, Product Access, and Supply Chain & Retail. The Commercial & Clinical division provides outsourced services encompassing sales, marketing, and integrated account management for pharmaceutical and medical device manufacturers, also managing the distribution and support for medical device producers. The Product Access division facilitates access to pharmaceutical and medical treatments through on-demand services, fostering vital connections between manufacturers and healthcare stakeholders; additionally, its exclusive access services establish tailored distribution agreements for crucial pharmaceutical brands. The Supply Chain & Retail division manages the pre-wholesale and wholesale distribution of pharmaceutical, healthcare, and animal health products to pharmacies, hospitals, and veterinary practices, and also oversees a network of retail pharmacies operating under the Life, Allcare, and Hickey's banners. Beyond its core divisional activities, Uniphar delivers a broad spectrum of specialized services, including pharmacy support, comprehensive pharmaceutical supply chain management, specialist nursing and infusion services, medical device distribution, and healthcare technology solutions. It further extends its expertise through data intelligence, consultancy, pharmaceutical advisory, and medical affairs services, alongside online pharmacy operations, product fostering, and data analytics for the pharmaceutical sector. Established in 1967, Uniphar plc maintains its headquarters in Dublin, Ireland.
Aktienkurs
$5.09
Zuletzt synchronisiert: 2026-07-31
Marktkapitalisierung
$1.32B
Veränderung (1 Tag)
1.06%
Veränderung (1 Jahr)
7.65%
Land
IE
Handel Uniphar plc (UPR)

Kategorie

Healthcare
Gewinn für Uniphar plc (UPR)
Gewinn im 2026 TTM: 0
Laut den aktuellen Finanzberichten von Uniphar plc betragen die aktuellen Gewinne des Unternehmens 0. Im Jahr 2026 erzielte das Unternehmen einen Gewinn von 0, gleich wie dem Gewinn im Jahr 2026, der 0 betrug. Die auf dieser Seite angezeigten Gewinne sind die Gewinne vor Zinsen und Steuern, auch bekannt als EBIT.
Gewinnverlauf von Uniphar plc von 2026 bis 2026
Gewinn am Ende jedes Jahres
Jahr Gewinn ändert
Nicht genügend Daten für die angegebenen Daten.
Gewinn ähnlicher Unternehmen oder Konkurrenten
Unternehmen Gewinn Gewinnunterschied Land
McKesson Corporation McKesson Corporation
McKesson Corporation
MCK.US
$6.46B -
US
Cencora, Inc. Cencora, Inc.
Cencora, Inc.
COR.US
- -
US
Cardinal Health, Inc. Cardinal Health, Inc.
Cardinal Health, Inc.
CAH.US
$2.17B -
US
AmerisourceBergen Corporation AmerisourceBergen Corporation
AmerisourceBergen Corporation
ABC.US
- -
US
Sigma Healthcare Limited Sigma Healthcare Limited
Sigma Healthcare Limited
SIG.AX
$358.16M -
AU